July 29, 2013 “Intelligence: Late Breaking Lab News”

Share on facebook
Share on twitter
Share on linkedin
Share on print
Share on email

Another national health insurance corporation is preparing to institute pre-authorization for genetic tests. Cigna Corporation announced on July 23 that it had selected InformedDNA, to administer its new genetic testing and counseling program. Pathologists and laboratory administrators should note that one goal of Cigna’s new program is “to prevent the ordering of inappropriate genetic tests,” according to its press release.

MORE ON: Cigna

Lab executives should expect more payers to institute these programs. One goal is to provide genetic counseling to patients. Equal emphasis will be given to how physicians utilize genetic tests. Managed care experts predict that payers will exclude most labs from providing genetic tests to their beneficiaries. One of the first national health insurance companies to initiate this type of program was Humana Inc., which selected DNA Direct to manage its genetic test program in July 2009. Humana now operates that program internally.

ZIMBABWE FORMS PATHOLOGY COLLEGE

Last month, the Zimbabwe Health and Child Welfare Deputy announced the launch of the first Zimbabwe College of Pathology (ZCP). This is another sign that health systems in developing nations in Africa are recognizing the need to upgrade diagnostic testing as a linchpin to improving patient outcomes.

TRANSITIONS

  • Sensus Healthcare of Boca Raton, Florida, named Clay Cockerell, M.D., as its Medical Director. Sensus is a medical device company with products used in the dermatology field. Cockerell is a noted dermatopathologist and dermatologist. He is director of Cockerell & Associates Dermpath Diagnostics and owner of Cockerell Dermatology Consulting  Services, both located in Dallas, Texas.
  • This month, Quest Diagnostics Incorporated named Mark J. Guinan as its new Senior Vice President and Chief Financial Officer. He has held executive positions with Hill-Rom Holdings Inc., Johnson & Johnson, and Procter & Gamble.
  • Leaving Quest Diagnostics this month in a planned transition is Robert A. Hagemann, currently Senior Vice President and Chief Financial Officer. Hagemann assumed this position in 1998. His past executive positions included Corning Life Sciences, Prime Hospitality, Inc., and Crompton & Knowles, Inc.

Dark Daily Update

dark_daily_logoHave you caught the latest e-briefings from DARK Daily? If so, then you’d know about…

…the recent study that determined that 30% of primary care physicians admit to overlooking essential clinical laboratory test results, mainly because of too many alerts from their electronic health record systems.

You can get the free DARK Daily e-briefings by signing up at www.darkdaily.com.

Comments

Leave a Reply

You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

Privacy Policy: We will never share your personal information.